Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study.

Barni S, Livraghi L, Gravina A, Martella F, D'Onofrio L, Morritti M, Michelotti A, Vici P, Mentuccia L, Porcu L, Orditura M, Puglisi F; ESEMPiO Group.

J Geriatr Oncol. 2019 May 13. pii: S1879-4068(19)30073-6. doi: 10.1016/j.jgo.2019.05.003. [Epub ahead of print] No abstract available.

PMID:
31097340
2.

Corrigendum to "A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation".

Mezzasalma V, Manfrini E, Ferri E, Sandionigi A, Ferla B, Schiano I, Michelotti A, Nobile V, Labra M, Di Gennaro P.

Biomed Res Int. 2019 Apr 9;2019:9042956. doi: 10.1155/2019/9042956. eCollection 2019.

3.

Prevalence of temporomandibular disorder pain, jaw noises and oral behaviours in an adult Italian population sample.

Iodice G, Cimino R, Vollaro S, Lobbezoo F, Michelotti A.

J Oral Rehabil. 2019 Apr 16. doi: 10.1111/joor.12803. [Epub ahead of print]

PMID:
30993737
4.

Jaw muscle activity patterns in women with chronic TMD myalgia during standardized clenching and chewing tasks.

Valentino R, Cioffi I, Vollaro S, Cimino R, Baiano R, Michelotti A.

Cranio. 2019 Mar 21:1-7. doi: 10.1080/08869634.2019.1589703. [Epub ahead of print]

PMID:
30896353
5.

Prevalence of malocclusion, oral parafunctions and temporomandibular disorder-pain in Italian schoolchildren: An epidemiological study.

Perrotta S, Bucci R, Simeon V, Martina S, Michelotti A, Valletta R.

J Oral Rehabil. 2019 Jul;46(7):611-616. doi: 10.1111/joor.12794. Epub 2019 May 7.

PMID:
30892729
6.

Occlusal sensitivity in individuals with different frequencies of oral parafunction.

Bucci R, Koutris M, Lobbezoo F, Michelotti A.

J Prosthet Dent. 2019 Mar 15. pii: S0022-3913(18)31001-1. doi: 10.1016/j.prosdent.2018.10.006. [Epub ahead of print]

PMID:
30885582
7.

Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.

Invernizzi M, Michelotti A, Noale M, Lopez G, Runza L, Giroda M, Despini L, Blundo C, Maggi S, Gambini D, Fusco N.

J Clin Med. 2019 Jan 24;8(2). pii: E138. doi: 10.3390/jcm8020138.

8.

Temporomandibular joint damage in juvenile idiopathic arthritis: Diagnostic validity of diagnostic criteria for temporomandibular disorders.

Rongo R, Alstergren P, Ammendola L, Bucci R, Alessio M, D'Antò V, Michelotti A.

J Oral Rehabil. 2019 May;46(5):450-459. doi: 10.1111/joor.12769. Epub 2019 Feb 14.

PMID:
30664807
9.

Effects of maxillary expansion on the upper airways: Evidence from systematic reviews and meta-analyses.

Bucci R, Montanaro D, Rongo R, Valletta R, Michelotti A, D'Antò V.

J Oral Rehabil. 2019 Apr;46(4):377-387. doi: 10.1111/joor.12766. Epub 2019 Feb 10. Review.

PMID:
30664799
10.

Standardizing Terminology and Assessment for Orofacial Conditions in Juvenile Idiopathic Arthritis: International, Multidisciplinary Consensus-based Recommendations.

Stoustrup P, Resnick CM, Pedersen TK, Abramowicz S, Michelotti A, Küseler A, Verna C, Kellenberger CJ, Nordal EB, Caserta G, Jankovska I, Halbig JM, Kristensen KD, Arvidsson LZ, Spiegel L, Stoll ML, Lerman M, Glerup M, Defabianis P, Frid P, Alstergren P, Cron RQ, Ringold S, Nørholt SE, Peltomäki T, Herlin T, Peacock ZS, Twilt M; TMJ Juvenile Arthritis Working Group.

J Rheumatol. 2019 May;46(5):518-522. doi: 10.3899/jrheum.180785. Epub 2019 Jan 15.

PMID:
30647179
11.

Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical management.

Michelotti A, Invernizzi M, Lopez G, Lorenzini D, Nesa F, De Sire A, Fusco N.

Breast. 2019 Apr;44:15-23. doi: 10.1016/j.breast.2018.12.009. Epub 2018 Dec 17. Review.

PMID:
30580170
12.

Prevalence of temporomandibular disorders and oral parafunctions in adolescents from public schools in Southern Italy.

Paduano S MD, DDS, Bucci R DDS, PhD, Rongo R DDS, PhD, Silva R DDS, Michelotti A DDS.

Cranio. 2018 Dec 14:1-6. doi: 10.1080/08869634.2018.1556893. [Epub ahead of print]

PMID:
30547719
13.

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.

Pizzuti L, Giordano A, Michelotti A, Mazzotta M, Natoli C, Gamucci T, De Angelis C, Landucci E, Diodati L, Iezzi L, Mentuccia L, Fabbri A, Barba M, Sanguineti G, Marchetti P, Tomao S, Mariani L, Paris I, Lorusso V, Vallarelli S, Cassano A, Airoldi F, Orlandi A, Moscetti L, Sergi D, Sarobba MG, Tonini G, Santini D, Sini V, Veltri E, Vaccaro A, Ferrari L, De Tursi M, Tinari N, Grassadonia A, Greco F, Botticelli A, La Verde N, Zamagni C, Rubino D, Cortesi E, Magri V, Pomati G, Scagnoli S, Capomolla E, Kayal R, Scinto AF, Corsi D, Cazzaniga M, Laudadio L, Forciniti S, Mancini M, Carbognin L, Seminara P, Barni S, Samaritani R, Roselli M, Portarena I, Russo A, Ficorella C, Cannita K, Carpano S, Pistelli M, Berardi R, De Maria R, Sperduti I, Ciliberto G, Vici P.

J Cell Physiol. 2019 Jun;234(6):7708-7717. doi: 10.1002/jcp.27832. Epub 2018 Dec 10.

PMID:
30536609
14.

Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study.

Barni S, Livraghi L, Morritti M, Vici P, Michelotti A, Cinieri S, Fontanella C, Porcu L, Del Mastro L, Puglisi F; ESEMPiO Study Group.

Future Oncol. 2019 Jan;15(1):33-44. doi: 10.2217/fon-2018-0324. Epub 2018 Nov 9.

PMID:
30411979
15.

Introduction by the Editor.

Michelotti A.

Orthod Craniofac Res. 2018 Nov;21(4):169. doi: 10.1111/ocr.12246. No abstract available.

PMID:
30351528
16.

Mind the Gap: A Systematic Review of Implementation of Screening for Psychological Comorbidity in Dental and Dental Hygiene Education.

Häggman-Henrikson B, Ekberg E, Ettlin DA, Michelotti A, Durham J, Goulet JP, Visscher CM, Raphael KG.

J Dent Educ. 2018 Oct;82(10):1065-1076. doi: 10.21815/JDE.018.104. Review.

17.

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.

Invernizzi M, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Fusco N.

BMC Cancer. 2018 Sep 29;18(1):935. doi: 10.1186/s12885-018-4851-2.

18.

Erratum to: Evaluation of masticatory muscle activity in patients with unilateral posterior crossbite before and after rapid maxillary expansion.

Michelotti A, Rongo R, Valentino R, D'Antò V, Bucci R, Danzi G, Cioffi I.

Eur J Orthod. 2019 Jan 23;41(1):109. doi: 10.1093/ejo/cjy054. No abstract available.

PMID:
30113622
19.

Cross-cultural differences in types and beliefs about treatment in women with temporomandibular disorder pain.

Al-Harthy M, List T, Ohrbach R, Michelotti A.

J Oral Rehabil. 2018 Sep;45(9):659-668. doi: 10.1111/joor.12683. Epub 2018 Jul 16.

PMID:
29974490
20.

Dental and skeletal long-term side effects of mandibular advancement devices in obstructive sleep apnea patients: a systematic review with meta-regression analysis.

Bartolucci ML, Bortolotti F, Martina S, Corazza G, Michelotti A, Alessandri-Bonetti G.

Eur J Orthod. 2019 Jan 23;41(1):89-100. doi: 10.1093/ejo/cjy036.

PMID:
29901715
21.

An interview with Ambrosina Michelotti.

Michelotti A.

Dental Press J Orthod. 2018 Mar-Apr;23(2):22-29. doi: 10.1590/2177-6709.23.2.022-029.int. No abstract available.

22.

The Role of Stress in the Etiology of Oral Parafunction and Myofascial Pain.

Ohrbach R, Michelotti A.

Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):369-379. doi: 10.1016/j.coms.2018.04.011. Epub 2018 Jun 1. Review.

PMID:
29866454
23.

Two repetitive bouts of intense eccentric-concentric jaw exercises reduce experimental muscle pain in healthy subjects.

Bucci R, Lobbezoo F, Michelotti A, Koutris M.

J Oral Rehabil. 2018 Aug;45(8):575-580. doi: 10.1111/joor.12656. Epub 2018 Jun 7.

PMID:
29782040
24.

Evaluation of masticatory muscle activity in patients with unilateral posterior crossbite before and after rapid maxillary expansion.

Michelotti A, Rongo R, Valentino R, D'Antò V, Bucci R, Danzi G, Cioffi I.

Eur J Orthod. 2019 Jan 23;41(1):46-53. doi: 10.1093/ejo/cjy019. Erratum in: Eur J Orthod. 2019 Jan 23;41(1):109.

PMID:
29688483
25.

Benefits of implementing pain-related disability and psychological assessment in dental practice for patients with temporomandibular pain and other oral health conditions.

Visscher CM, Baad-Hansen L, Durham J, Goulet JP, Michelotti A, Roldán Barraza C, Häggman-Henrikson B, Ekberg E, Raphael KG.

J Am Dent Assoc. 2018 Jun;149(6):422-431. doi: 10.1016/j.adaj.2017.12.031. Epub 2018 Apr 10.

PMID:
29653670
26.

Analysis of the reliability of the Italian version of the Oral Behaviours Checklist and the relationship between oral behaviours and trait anxiety in healthy individuals.

Donnarumma V, Cioffi I, Michelotti A, Cimino R, Vollaro S, Amato M.

J Oral Rehabil. 2018 Apr;45(4):317-322. doi: 10.1111/joor.12614. Epub 2018 Feb 21.

PMID:
29420851
27.

Into the future.

Michelotti A.

Orthod Craniofac Res. 2018 Feb;21(1):3. doi: 10.1111/ocr.12217. No abstract available.

PMID:
29346840
28.

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Pizzuti L, Sergi D, Sperduti I, Lauro LD, Mazzotta M, Botti C, Izzo F, Marchetti L, Tomao S, Marchetti P, Natoli C, Grassadonia A, Gamucci T, Mentuccia L, Magnolfi E, Vaccaro A, Cassano A, Rossi E, Botticelli A, Sini V, Sarobba MG, Fabbri MA, Moscetti L, Astone A, Michelotti A, De Angelis C, Bertolini I, Angelini F, Ciliberto G, Maugeri-Saccà M, Giordano A, Barba M, Vici P.

Cancer Biol Ther. 2018 Apr 3;19(4):328-334. doi: 10.1080/15384047.2017.1416938. Epub 2018 Feb 16.

29.

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results.

De Placido S, Giuliano M, Schettini F, Von Arx C, Buono G, Riccardi F, Cianniello D, Caputo R, Puglisi F, Bonotto M, Fabi A, Bilancia D, Ciccarese M, Lorusso V, Michelotti A, Bruzzese D, Veneziani BM, Locci M, De Laurentiis M, Arpino G.

Breast. 2018 Apr;38:86-91. doi: 10.1016/j.breast.2017.12.012. Epub 2018 Jan 4.

PMID:
29287189
30.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.

Vici P, Pizzuti L, Michelotti A, Sperduti I, Natoli C, Mentuccia L, Di Lauro L, Sergi D, Marchetti P, Santini D, Magnolfi E, Iezzi L, Moscetti L, Fabbri A, Cassano A, Grassadonia A, Omarini C, Piacentini F, Botticelli A, Bertolini I, Scinto AF, Zampa G, Mauri M, D'Onofrio L, Sini V, Barba M, Maugeri-Saccà M, Rossi E, Landucci E, Tomao S, Alberti AM, Giotta F, Ficorella C, Adamo V, Russo A, Lorusso V, Cannita K, Barni S, Laudadio L, Greco F, Garrone O, Della Giulia M, Marolla P, Sanguineti G, Di Cocco B, Ciliberto G, De Maria R, Gamucci T.

Oncotarget. 2017 May 25;8(34):56921-56931. doi: 10.18632/oncotarget.18176. eCollection 2017 Aug 22.

31.

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.

Cazzaniga ME, Airoldi M, Arcangeli V, Artale S, Atzori F, Ballerio A, Bianchi GV, Blasi L, Campidoglio S, Ciccarese M, Cursano MC, Piezzo M, Fabi A, Ferrari L, Ferzi A, Ficorella C, Frassoldati A, Fumagalli A, Garrone O, Gebbia V, Generali D, La Verde N, Maur M, Michelotti A, Moretti G, Musolino A, Palumbo R, Pistelli M, Porpiglia M, Sartori D, Scavelli C, Schirone A, Turletti A, Valerio MR, Vici P, Zambelli A, Clivio L, Torri V; on behalf of; EVA Study Group.

Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.

PMID:
28711793
32.

Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.

Gamucci T, Pizzuti L, Sperduti I, Mentuccia L, Vaccaro A, Moscetti L, Marchetti P, Carbognin L, Michelotti A, Iezzi L, Cassano A, Grassadonia A, Astone A, Botticelli A, Magnolfi E, Di Lauro L, Sergi D, Fuso P, Tinari N, Barba M, Maugeri-Saccà M, Landucci E, Conti F, Sanguineti G, De Tursi M, Iafrate G, Giordano A, Ciliberto G, Natoli C, Vici P.

J Cell Physiol. 2018 Mar;233(3):2313-2323. doi: 10.1002/jcp.26103. Epub 2017 Sep 27.

PMID:
28710865
33.

Digital evaluation of nasal changes induced by rapid maxillary expansion with different anchorage and appliance design.

Fastuca R, Lorusso P, Lagravère MO, Michelotti A, Portelli M, Zecca PA, D' Antò V, Militi A, Nucera R, Caprioglio A.

BMC Oral Health. 2017 Jul 14;17(1):113. doi: 10.1186/s12903-017-0404-3.

34.

Translation and validation of the italian version of the Psychosocial Impact of Dental Aesthetics Questionnaire (pidaq) among adolescents.

Bucci R, Rongo R, Zito E, Valletta R, Michelotti A, D'anto V.

Eur J Paediatr Dent. 2017 Jun;18(2):158-162. doi: 10.23804/ejpd.2017.18.02.13.

35.

Delayed-onset muscle soreness does not influence occlusal sensitivity and position sense of the mandible.

Bucci R, Lobbezoo F, Michelotti A, Orfanou C, Koutris M.

J Oral Rehabil. 2017 Sep;44(9):655-663. doi: 10.1111/joor.12528. Epub 2017 Jul 10.

PMID:
28548304
36.

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.

Generali D, Montemurro F, Bordonaro R, Mafodda A, Romito S, Michelotti A, Piovano P, Ionta MT, Bighin C, Sartori D, Frassoldati A, Cazzaniga ME, Riccardi F, Testore F, Vici P, Barone CA, Schirone A, Piacentini F, Nolè F, Molino A, Latini L, Simoncini EL, Roila F, Cognetti F, Nuzzo F, Foglietta J, Minisini AM, Goffredo F, Portera G, Ascione G, Mariani G.

Oncologist. 2017 Jun;22(6):648-654. doi: 10.1634/theoncologist.2016-0461. Epub 2017 Apr 21.

37.

Letters From Our Readers.

Rongo R, Valletta R, Bucci R, Rivieccio V, Galeotti A, Michelotti A, D'Antò V.

Angle Orthod. 2017 May;87(3):486. doi: 10.2319/0003-3219-87.3.486. No abstract available.

PMID:
28426323
38.

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

Dieci MV, Frassoldati A, Generali D, Bisagni G, Piacentini F, Cavanna L, Cagossi K, Puglisi F, Michelotti A, Berardi R, Banna G, Goubar A, Ficarra G, Griguolo G, Conte P, Guarneri V.

Breast Cancer Res Treat. 2017 Jun;163(3):637. doi: 10.1007/s10549-017-4219-3. No abstract available.

PMID:
28374322
39.

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

Dieci MV, Frassoldati A, Generali D, Bisagni G, Piacentini F, Cavanna L, Cagossi K, Puglisi F, Michelotti A, Berardi R, Banna G, Goubar A, Ficarra G, Griguolo G, Conte P, Guarneri V.

Breast Cancer Res Treat. 2017 Jun;163(2):295-302. doi: 10.1007/s10549-017-4191-y. Epub 2017 Mar 13. Erratum in: Breast Cancer Res Treat. 2017 Jun;163(3):637.

PMID:
28289852
40.

Effect of weather on temporal pain patterns in patients with temporomandibular disorders and migraine.

Cioffi I, Farella M, Chiodini P, Ammendola L, Capuozzo R, Klain C, Vollaro S, Michelotti A.

J Oral Rehabil. 2017 May;44(5):333-339. doi: 10.1111/joor.12498. Epub 2017 Mar 30.

PMID:
28244179
41.

Influence of culture on pain comorbidity in women with and without temporomandibular disorder-pain.

Al-Harthy M, Michelotti A, List T, Ohrbach R.

J Oral Rehabil. 2017 Jun;44(6):415-425. doi: 10.1111/joor.12499. Epub 2017 Mar 21.

PMID:
28244114
42.

Skeletal and dental effects of Class III orthopaedic treatment: a systematic review and meta-analysis.

Rongo R, D'Antò V, Bucci R, Polito I, Martina R, Michelotti A.

J Oral Rehabil. 2017 Jul;44(7):545-562. doi: 10.1111/joor.12495. Epub 2017 Mar 30. Review.

PMID:
28214379
43.

Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.

Cestone E, Michelotti A, Zanoletti V, Zanardi A, Mantegazza R, Dossena M.

J Cosmet Dermatol. 2017 Jun;16(2):265-270. doi: 10.1111/jocd.12309. Epub 2017 Jan 29.

PMID:
28133878
44.

Erratum to: Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.

Mezzasalma V, Manfrini E, Ferri E, Boccarusso M, Di Gennaro P, Schiano I, Michelotti A, Labra M.

Arch Gynecol Obstet. 2017 Feb;295(2):527. doi: 10.1007/s00404-016-4280-x. No abstract available.

PMID:
28012076
45.

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Lambertini M, Ceppi M, Cognetti F, Cavazzini G, De Laurentiis M, De Placido S, Michelotti A, Bisagni G, Durando A, Valle E, Scotto T, De Censi A, Turletti A, Benasso M, Barni S, Montemurro F, Puglisi F, Levaggi A, Giraudi S, Bighin C, Bruzzi P, Del Mastro L; MIG and GIM study groups.

Eur J Cancer. 2017 Jan;71:34-42. doi: 10.1016/j.ejca.2016.10.030. Epub 2016 Dec 10.

PMID:
27951450
46.

Dentoskeletal effects of oral appliance wear in obstructive sleep apnoea and snoring patients.

Alessandri-Bonetti G, D'Antò V, Stipa C, Rongo R, Incerti-Parenti S, Michelotti A.

Eur J Orthod. 2017 Oct 1;39(5):482-488. doi: 10.1093/ejo/cjw078.

PMID:
27932405
47.

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.

Gamucci T, Mentuccia L, Natoli C, Sperduti I, Cassano A, Michelotti A, Di Lauro L, Sergi D, Fabi A, Sarobba MG, Marchetti P, Barba M, Magnolfi E, Maugeri-Saccà M, Rossi E, Sini V, Grassadonia A, Pellegrini D, Astone A, Nisticò C, Angelini F, Vaccaro A, Pellegrino A, De Angelis C, Palleschi M, Moscetti L, Bertolini I, Buglioni S, Giordano A, Pizzuti L, Vici P.

J Cell Physiol. 2017 Jun;232(6):1571-1578. doi: 10.1002/jcp.25685. Epub 2016 Nov 30.

48.

Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.

Mezzasalma V, Manfrini E, Ferri E, Boccarusso M, Di Gennaro P, Schiano I, Michelotti A, Labra M.

Arch Gynecol Obstet. 2017 Jan;295(1):163-172. doi: 10.1007/s00404-016-4235-2. Epub 2016 Nov 9. Erratum in: Arch Gynecol Obstet. 2017 Feb;295(2):527.

PMID:
27826653
49.

Self-management programmes in temporomandibular disorders: results from an international Delphi process.

Durham J, Al-Baghdadi M, Baad-Hansen L, Breckons M, Goulet JP, Lobbezoo F, List T, Michelotti A, Nixdorf DR, Peck CC, Raphael K, Schiffman E, Steele JG, Story W, Ohrbach R.

J Oral Rehabil. 2016 Dec;43(12):929-936. doi: 10.1111/joor.12448. Epub 2016 Nov 1.

PMID:
27727477
50.

Late-Developing Supernumerary Premolars: Analysis of Different Therapeutic Approaches.

Paduano S, Rongo R, Lucchese A, Aiello D, Michelotti A, Grippaudo C.

Case Rep Dent. 2016;2016:2020489. Epub 2016 Sep 28.

Supplemental Content

Loading ...
Support Center